[65] and [66] performed survival analysis using individual EMT hallmark molecules such as E-cadherin and vimentin and showed that none of these molecules could separate LUAD or bladder cancer patients into significantly different prognostic groups. The gene discussed is CDH1; the disease is urinary bladder cancer.